Two studies find Botox injections help reduce nighttime teeth grinding
May 1, 2012
by Bob Yirka
in Medications
(Medical Xpress) -- Two groups working independently have found that patients who suffer from nighttime teeth grinding, a condition known as nocturnal bruxism, found relief after being injected in their temple and jaw muscles with Botox. Both groups reported on their findings at this year’s American Academy of Neurology meeting.
Many people grind their teeth at night when they are asleep, though some may be unaware of doing so. It’s the degree that matters. Some grind slightly and experience no negative consequences other than annoying their sleeping partner. Other’s however experience much more serious consequences such as teeth problems, jaw and facial pain and headaches. There is currently no known cure for the condition and treatment usually consists of issuing patients mouth guards which do protect the teeth, but don’t alleviate pain or headaches. Patients with severe symptoms clearly need something better and that is why researchers have started looking into the therapeutic possibilities of botulinum toxin, more commonly known as Botox; the very same material used for cosmetic purposes.
In the first study, a team from the University of Texas Health Science Center in Houston, injected 23 people who suffered from severe bruxism. Thirteen got Botox while ten received a placebo. Four weeks later all of participants were tested to see what impact, if any, the injections had had on their teeth grinding and quality of sleep.
Testing results were measured in two ways, via polysomnography and by reports from the patients themselves which also included comments by sleep partners.
Polysomnography is a rigorous set of tests that have been developed for sleep studies with many parameters involved to determine the quality of sleep people experience and also to account for such problems as headaches, pain, or other situations that arise due to sleep issues. In the Houston study, the results of the Polysomnography, called a polysomnogram, were averaged together with numbers given by patients to self-assess their quality of sleep. Taken together the team found the average numbers jumping from 47.3 for bruxism patients to 64.5 after receiving Botox injections. The numbers for the placebo patients didn’t change. In addition, the team found that numbers for pain experienced increased as well, from 44.2 to 65.0 (higher means less pain). Overall, the team says, the results indicated that injecting Botox provided significant relief for all of the patients who received it, while the only side effects were slight changes in appearance for some when smiling.
In the second study, doctors at the Henry Ford Medical Center in Detroit, injected four patients who were experiencing severe bruxism following head injuries, with Botox and reported at the conference that all four showed relief from the condition without any noticeable adverse side effects.
Both groups are careful to point out that much more robust studies will need to be undertaken with the results published in a medical journal before Botox can be claimed to be a true therapy for bruxism. On the other hand, since Botox can already be administered for other reasons, there is nothing stopping doctors from giving patients suffering from bruxism injections right away to try to help them.
© 2012 Phys.Org
-
Teeth grinding linked to sleep apnea
Nov 02, 2009 |
not rated yet |
0
-
Mayo Clinic finds botox eases painful spinal headaches
Apr 14, 2011 |
not rated yet |
0
-
Botox reduces wrinkles even in less frequent doses
Apr 26, 2010 |
not rated yet |
0
-
Botox injections can significantly improve quality of life for people with overactive bladders
Jun 09, 2009 |
not rated yet |
0
-
Botox to iron out Australian asthma wrinkles
Jun 28, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
-
Marie Curie's leukemia
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Breakup of physician, drug company relationship could improve health care, cut cost
A new report suggests that improved health care and significant reductions in drug costs might be attained by breaking up the age-old relationship between physicians and drug company representatives who promote the newest, ...
Medications
11 hours ago |
5 / 5 (1) |
0
FDA has safety concerns on Merck insomnia drug
Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking.
Medications
12 hours ago |
not rated yet |
0
US adviser on board of firm that sold anthrax drug
(AP)—Former Navy Secretary Richard J. Danzig, who has served as a bio-warfare adviser to the president, the Pentagon, and the Department of Homeland Security, urged the government to stockpile an anti-anthrax drug while ...
Medications
18 hours ago |
5 / 5 (1) |
0
Acne pill benefits outweigh blood clot risk: EU agency
Europe's medicines watchdog said Friday the benefits of acne drug Diane-35, also widely used as a contraceptive, outweigh the risk of developing blood clots in the veins—when correctly prescribed.
Medications
May 17, 2013 |
not rated yet |
0
First influenza vaccine brought to clinical testing
Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their ...
Medications
May 17, 2013 |
5 / 5 (1) |
1
The compound in the Mediterranean diet that makes cancer cells 'mortal'
New research suggests that a compound abundant in the Mediterranean diet takes away cancer cells' "superpower" to escape death. By altering a very specific step in gene regulation, this compound essentially re-educates cancer ...
Do salamanders hold the solution to regeneration?
Salamanders' immune systems are key to their remarkable ability to regrow limbs, and could also underpin their ability to regenerate spinal cords, brain tissue and even parts of their hearts, scientists have ...
Scientists identify molecular trigger for Alzheimer's disease
Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease – when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons ...
Practice makes perfect? Not so much
Turns out, that old "practice makes perfect" adage may be overblown. New research led by Michigan State University's Zach Hambrick finds that a copious amount of practice is not enough to explain why people ...
Older prostate cancer patients should think twice before undergoing treatment
Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA ...
New test better detects elephantiasis worm infection
A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a field ...